Professor, Medicine, University of Texas Medical School, San Antonio
Pulmonology
Dr. Antonio Anzueto, MD
|
|
Give Review
Antonio Anzueto works in the field of Pulmonology. He received awards:"CMS Meaningful Use Stage 1 Certification". Antonio Anzueto is also a published doctor. He has 34 paper published. The most recent paper is: Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial. Antonio Anzueto is registered with Medicare and accepts Medicare payments.
Publications
- Role of infection in exacerbations of chronic obstructive pulmonary disease.
- Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia.
- Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinic...
- Reply: Azithromycin: We're There!
- Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet?
- Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia.
- Antibiotic prophylaxis IN COPD: why, when, and for whom?
- Predictors of rehospitalization after admission for pneumonia in the veterans affairs healthcare system.
- Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease.
- Tiotropium Respimat inhaler and the risk of death in COPD.
- A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium.
- Predictors of Long-term Mortality After Severe Sepsis in the Elderly.
- What is the Best Antimicrobial Treatment for Severe Community-Acquired Pneumonia (Including the Role of Steroids and Statins and Other Immunomodulatory Agents).
- Long-term prognosis in community-acquired pneumonia.
- THE PARADOXICAL EFFECT ON PNEUMONIA OF CHRONIC INHALED CORTICOSTEROIDS.
- Inhaled corticosteroid effects on pneumonia severity and antimicrobial resistance.
- Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission.
- Impact of prior systemic corticosteroid use in patients admitted with community-acquired pneumonia.
- Pneumonia: an arrhythmogenic disease?
- Impact of obesity on outcomes for patients hospitalised with pneumonia.
- Population-Based Study of Statins, ARBs, and ACE inhibitors on Pneumonia-Related Outcomes.
- Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia*.
- Identifying patients at risk of late recovery (≥8 days) from acute exacerbation of chronic bronchitis and COPD.
- HYPOCAPNIA AND HYPERCAPNIA ARE PREDICTORS FOR ICU ADMISSION AND MORTALITY IN HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA.
- Global trends in community-acquired pneumonia.
- Evaluation of the IDSA/ATS minor criteria for severe community-acquired pneumonia.
- Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia.
- Association of hydrophilic versus lipophilic angiotensin-converting enzyme inhibitor use on pneumonia-related mortality.
- Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.
- A score to predict short-term risk of COPD exacerbations (SCOPEX).
- Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.
- Non-invasive mechanical ventilation and mortality in elderly immunocompromised patients hospitalized with pneumonia: a retrospective cohort study.
- The association of cardioprotective medications with pneumonia-related outcomes.
Schools
Universidad Mariano Galvez De Guatemala Facultad De Ciencias Medicas Y De La Salud
Hospital Gen San Juan De Dios University De San Carlo
University Tex Health Science Center
Doctors Specialties
- Internal Medicine
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Texas Health Science Center -
Universidad de San Carlos FOMS
Hospital
-
South Texas Veterans Health Care System -
University Health System
Drug Facts
| NPI NUMBER | 1053428128 | |
| NPPES Provider LastName | ANZUETO | |
| NPPES Provider FirstName | ANTONIO | |
| NPPES Provider ZIPCode | 782293901 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 237.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1053428128 |
| Last Name Of The Provider | ANZUETO |
| First Name Of The Provider | ANTONIO |
| View All |
Similar Doctors
|
|
Dr. Seema Baranwal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul M. Silva, MD |
|
|
Dr. Nora L. Walker, MD |
|
Dr. David Salazar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael R. Natalino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer D. Brody, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew L. Walsh III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth G. Torrington, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Shelby E. Sutton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juan C Gonzalez, MD |
|
Dr. Kevin B. Horton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin J. Wiesenthal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric L. Madarang, DO
This Doctor is OpenDoctor Recommended.
|